#Neurodegenerative diseases are incurable, progressive conditions—such as Alzheimer’s, Parkinson’s, Multiple Sclerosis—that cause neurons in the brain or spinal cord to lose function and eventually die. They primarily result in debilitating cognitive decline (dementia), motor dysfunction, and sometimes paralysis.
Cerebrospinal fluid (hashtag#CSF) is a critical biofluid for neurodegenerative disease research, offering direct, real-time insights into brain pathophysiology. Key applications include biomarker discovery for Alzheimer’s (A$\beta$42, T-tau, P-tau), Parkinson’s, ALS, and dementia to aid early diagnosis, disease staging, and monitoring therapeutic effects. Standardized, high-quality samples are vital.
Core Challenges in CSF Research
Sample Quality: Due to inter-individual variability, strict standardization in lumbar puncture, collection, and storage protocols is required to ensure sample stability.
Access: High-quality CSF samples, especially from healthy controls, are limited, making collaborative biobanking crucial.
Variability: Researchers are addressing inter-individual variability in protein levels to improve diagnostic accuracy
Please reach out to bd@cell-bio.life to find out more about CSF and PBMC collections from Normal controls and neurodegenerative disorders populations.